CD5 expression by dendritic cells drives T cell immunity and sustains immunotherapy responses | Science End-shutdown



CD5 on dendritic cells is immunostimulatory and potentiates tumor-specific T cell responses during immunotherapy.


Leave a Reply

Your email address will not be published. Required fields are marked *